
D-3-(3-Benzothienyl)alanine | CAS:111139-55-0
D-3-(3-Benzothienyl)alanine
- 名称:D-3-(3-苯并噻吩基)丙氨酸 | D-3-(3-Benzothienyl)alanine
- CAS号:111139-55-0
- 别名:
- 分子式:C11H11NO2S
- 分子量:221.28
- EINESC号:
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
Combi-Blocks | 浏览或下载 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis.L Axelrod et al.Diabetes, 31(11), 994-1001 (1982-11-01)
In vitro effects of theophylline on insulin receptors in adipocytes: correlation with the lipolytic action of the agent.H J Steinfelder et al.Biochemical and biophysical research communications, 104(1), 45-51 (1982-01-15)
The development of tolerance to antilipolytic agents in rats.D D Myles et al.Biochemical pharmacology, 34(2), 269-274 (1985-01-15)
Regulation of renal and hepatic pyruvate dehydrogenase complex on carbohydrate re-feeding after starvation. Possible mechanisms and a regulatory role for thyroid hormone.M J Holness et al.The Biochemical journal, 241(2), 421-425 (1987-01-15)
Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.Takeshi Fukushima et al.Chirality, 21(4), 468-472 (2008-07-26)
Effects of administration of tri-iodothyronine on the response of cardiac and renal pyruvate dehydrogenase complex to starvation for 48 h.M J Holness et al.The Biochemical journal, 232(1), 255-259 (1985-11-15)
Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.Michael Williams Biochemical pharmacology, 78(11), 1360-1365 (2009-07-14)
Alterations in extracellular tryptophan and dopamine concentrations in rat striatum following peripheral administration of D- and L-tryptophan: an in vivo microdialysis study.Shunsuke Yoshihara et al.Neuroscience letters, 526(1), 74-78 (2012-08-14)
[Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives. Identification and lipolysis inhibitory activity (author's transl)].K Credner et al.Arzneimittel-Forschung, 31(12), 2096-2100 (1981-01-01)
In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.Tiziana Adage et al.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 18(3), 200-214 (2007-08-08)
A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats.Nian Gong et al.The Journal of pharmacology and experimental therapeutics, 336(1), 282-293 (2010-10-19)
Effects of adrenaline on ketogenesis from long- and medium-chain fatty acids in starved rats.M C Sugden et al.The Biochemical journal, 204(3), 749-756 (1982-06-15)
Effects of nutritional status and acute variation in substrate supply on cardiac and skeletal-muscle fructose 2,6-bisphosphate concentrations.T J French et al.The Biochemical journal, 250(3), 773-779 (1988-03-15)
The development of tolerance to antilipolytic agents by isolated rat adipocytes.G D Stratton et al.Biochemical pharmacology, 34(2), 275-279 (1985-01-15)
Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.Kana Ishii et al.Chirality, 22(10), 901-906 (2010-09-28)
Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.Naomi Haruta et al.Proceedings of the Japan Academy. Series B, Physical and biological sciences, 87(10), 641-648 (2011-12-14)
The effect of 5-methylpyrazole-3-carboxylate and nicotinic acid on abnormalities of carbohydrate metabolism in alloxan-diabetic rat muscle.A McAllister et al.Biochemical pharmacology, 31(1), 63-68 (1982-01-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!